Pacira BioSciences, Inc. (PCRX) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$3,421
Total Return
-65.79%
CAGR
-19.31%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -0.98% |
| Median | -1.39% |
| Best | +47.23% |
| Worst | -46.35% |
| % of Windows Positive | 44.2% |
1-Year (252 Trading Days)
| Average | -16.20% |
| Median | -21.76% |
| Best | +114.02% |
| Worst | -69.26% |
| % of Windows Positive | 19.5% |
3-Year (756 Trading Days)
| Average | -58.54% |
| Median | -59.11% |
| Best | -32.66% |
| Worst | -80.80% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -85.67% |
| Average Drawdown | -50.57% |
| Drawdown Duration | 1004 Trading Days (Unrecovered) |
| Sortino Ratio | -0.28 |
| Calmar Ratio | -0.23 |
| CVaR (5%) | -6.33% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -8.23% (-26.04% ann.) | $823.03 | $0.00 | $0.00 | $0.00 |
| 2025 | +37.37% | +$3736.73 | $0.00 | $0.00 | $0.00 |
| 2024 | -44.16% | $4416.12 | $0.00 | $0.00 | $0.00 |
| 2023 | -12.61% | $1261.33 | $0.00 | $0.00 | $0.00 |
| 2022 | -35.83% | $3583.18 | $0.00 | $0.00 | $0.00 |
| 2021 | +0.55% | +$55.15 | $0.00 | $0.00 | $0.00 |
| 2020 | +32.10% | +$3209.71 | $0.00 | $0.00 | $0.00 |
| 2019 | +5.30% | +$529.99 | $0.00 | $0.00 | $0.00 |
| 2018 | -5.76% | $576.12 | $0.00 | $0.00 | $0.00 |
| 2017 | +41.33% | +$4133.13 | $0.00 | $0.00 | $0.00 |
| 2016 | -57.94% | $5793.72 | $0.00 | $0.00 | $0.00 |
| 2015 | -13.39% | $1338.82 | $0.00 | $0.00 | $0.00 |
| 2014 | +54.22% | +$5421.81 | $0.00 | $0.00 | $0.00 |
| 2013 | +229.08% | +$22907.84 | $0.00 | $0.00 | $0.00 |
| 2012 | +101.97% | +$10196.53 | $0.00 | $0.00 | $0.00 |
| 2011 partial | +23.22% (+26.00% ann.) | +$2321.94 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Policy-led rebound / euro-sovereign-crisis overlay partial | February 3, 2011 – July 25, 2012 | +105.70% | +63.17% | +$10569.80 | $0.00 | $0.00 | $0.00 |
| Secular stagnation / QE / low inflation / duration bull | July 26, 2012 – February 19, 2020 | +238.45% | +17.48% | +$23845.13 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -43.22% | -99.84% | $4322.27 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +66.73% | +127.63% | +$6673.27 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -10.96% | -10.43% | $1095.82 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -6.88% | -7.29% | $687.95 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -72.61% | -50.28% | $7261.45 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +62.12% | +36.07% | +$6211.60 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.